AnalystsAdam VogelAdam Vogel's Stock Forecasts
AnalystsAdam Vogel
Sectors:
Industries:
Analyst Ranking
Top 34%
#1881 out of 5549 analysts
Average Return
+21.58%
Win Rate
44%4 out of 9
Risk vs Reward
Poor
Good
Adam Vogel's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Immunome IncIMNM | +154.37% | $10.52 | $26.76 | 2025-09-05 - 2026-09-04 | Buy |
Apogee Therapeutics IncAPGE | +148.52% | $54.35 | $135.07 | 2025-11-03 - 2026-09-03 | Buy |
Lb Pharmaceuticals IncLBRX | +64.95% | $24.34 | $40.15 | 2026-04-10 - 2026-10-29 | Buy |
Pepgen IncPEPG | +51.57% | $1.59 | $2.41 | 2026-06-16 - 2026-10-29 | Buy |
Adam Vogel Analyst Color
Get additional color on Adam Vogel's coverage of popular stocks
Adam Vogel's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Satellos Bioscience IncMSLE | 1 | Buy | $24.00 | +252.16% | Initiates Coverage On | 22 days ago |
Alterity Therapeutics LtdATHE | 1 | Buy | $12.00 | +437.39% | Initiates Coverage On | 3 months ago |
Maplight Therapeutics IncMPLT | 2 | Buy | $40.00 | +418.13% | Maintains | 4 months ago |
Pepgen IncPEPG | 1 | Buy | $11.00 | +356.43% | Initiates Coverage On | 4 months ago |
Lb Pharmaceuticals IncLBRX | 1 | Buy | $36.00 | -10.34% | Initiates Coverage On | 7 months ago |
Immunome IncIMNM | 2 | Buy | $36.00 | +96.83% | Maintains | 8 months ago |
Apogee Therapeutics IncAPGE | 1 | Buy | $109.00 | -19.30% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.